jueves, 4 de enero de 2024

Toripalimab Becomes First Immunotherapy Drug Approved for Nasopharyngeal Cancer

https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-toripalimab-nasopharyngeal-cancer?cid=eb_govdel

No hay comentarios:

Publicar un comentario